![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1703418
¼¼°èÀÇ ¾à¹° ¿ëÃâ ½ºÅÙÆ® ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø - ÄÚÆÃ À¯Çüº°(Æú¸®¸Ó ±â¹Ý ÄÚÆÃ, Æú¸®¸Ó ÇÁ¸® ÄÚÆÃ), ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Coating Type (Polymer-based Coatings, Polymer-free Coatings), By Application, By Region & Competition, 2020-2030F |
¾à¹° ¿ëÃâ ½ºÅÙÆ®(DES) ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 83¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â±îÁö 8.08%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
¼¼°è ÇコÄÉ¾î ºÐ¾ß, ƯÈ÷ ±â¼ú ¹× Çõ½Å ºÐ¾ßÀÇ Å« ¹ßÀüÀº ȯÀÚ Ä¡·á¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü ¼Ó¿¡¼ ¾à¹° ¿ëÃâ ½ºÅÙÆ®´Â ÁßÀçÀû ½ÉÀåÇÐ ºÐ¾ßÀÇ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. ÀÌ ÀÛÁö¸¸ Áß¿äÇÑ ÀÇ·á±â±â´Â °ü»óµ¿¸ÆÁúȯ(CAD) °ü¸®¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, Àü ¼¼°è DES ½ÃÀåÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä | |
---|---|
¿¹Ãø ±â°£ | 2026-2030³â |
½ÃÀå ±Ô¸ð : 2024³â | 83¾ï ´Þ·¯ |
½ÃÀå ±Ô¸ð : 2030³â | 132¾ï 6,000¸¸ ´Þ·¯ |
CAGR : 2025-2030³â | 8.08% |
±Þ¼ºÀå ºÎ¹® | Æú¸®¸Ó º£À̽º ÄÚÆÃ |
ÃÖ´ë ½ÃÀå | ºÏ¹Ì |
¾à¹° ¿ëÃâ ½ºÅÙÆ®´Â °ü»óµ¿¸Æ ÁúȯÀ» Ä¡·áÇÏ°í µ¿¸Æ ÀçÇùÂøÀÇ °¡´É¼ºÀ» ÁÙÀ̱â À§ÇØ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. Ç×ÀçÇùÂøÁ¦·Î ÄÚÆÃµÈ ±Ý¼Ó ¸Þ½¬ Æ©ºê·Î ±¸¼ºµÈ DES´Â µ¿¸ÆÀÇ °³Å뼺À» À¯ÁöÇÏ´Â ±¸Á¶Àû ÁöÁöü·Î¼ÀÇ ±â´É°ú ¾à¹°À» Á¦¾îÀûÀ¸·Î ¹æÃâÇÏ´Â Àü´Þ ½Ã½ºÅÛÀ¸·Î¼ÀÇ ±â´ÉÀ» °âºñÇϰí ÀÖ½À´Ï´Ù. ÀÌ µÎ °¡Áö ±â´ÉÀ» ÅëÇØ ÇùÂø ¶Ç´Â Æó»öµÈ °ü»óµ¿¸Æ¿¡ DES¸¦ »ðÀÔÇÑ ÈÄ ÀçÇùÂøÀ» ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¼°è Àα¸ÀÇ °í·ÉÈ
±ÔÁ¦»óÀÇ Àå¾Ö¹°
±â¼ú ¹ßÀü
Global Drug-eluting stent (DES) market was valued at USD 8.30 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 8.08% through 2030. Significant advancements within the global healthcare sector-particularly in technology and innovation-have played a critical role in enhancing patient care and treatment outcomes. Among these advancements, drug-eluting stents have emerged as a transformative solution in interventional cardiology. These small yet vital medical devices are revolutionizing the management of coronary artery disease (CAD), thereby fueling notable expansion in the global DES market.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 8.30 Billion |
Market Size 2030 | USD 13.26 Billion |
CAGR 2025-2030 | 8.08% |
Fastest Growing Segment | Polymer-based Coatings |
Largest Market | North America |
Drug-eluting stents are specialized medical devices used to treat coronary artery disease and reduce the likelihood of arterial re-narrowing. Comprising a metallic mesh tube coated with an anti-restenotic drug, DES function both as a structural support to maintain arterial patency and as a delivery system for controlled drug release. This dual function helps prevent restenosis following implantation in narrowed or blocked coronary arteries..
Key Market Drivers
Aging Global Population
The growing elderly population is a major driver of the DES market, as older individuals are more vulnerable to cardiovascular diseases, particularly CAD. With global life expectancy on the rise, demand for minimally invasive cardiac treatments is expected to increase. According to the World Health Organization, the global population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030 and reach 2.1 billion by 2050. The 80+ age group is also set to triple, rising to 426 million by 2050. This demographic shift has far-reaching implications for healthcare providers and device manufacturers, as cardiovascular treatments such as DES become increasingly essential.
Key Market Challenges
Regulatory Hurdles
One of the primary challenges for the DES market is the constantly evolving regulatory landscape. Regulatory bodies across various regions frequently revise guidelines governing medical devices. As a result, manufacturers must allocate significant resources to ensure ongoing compliance. Securing approvals for new or modified products can be both time-intensive and costly, potentially delaying market entry and impacting profitability.
Key Market Trends
Technological Advancements
Technological innovation is significantly reshaping the global healthcare landscape, with drug-eluting stents at the forefront of progress in interventional cardiology. One of the most notable advancements is the use of biocompatible polymers that optimize drug release kinetics and reduce adverse patient reactions such as inflammation or allergies.
In addition, bioabsorbable stents represent a cutting-edge development. Designed to gradually dissolve within the body, these stents eliminate the long-term complications often associated with permanent metal implants, such as late-stage thrombosis. These innovations are expected to enhance treatment outcomes and further stimulate market growth in the coming years.
In this report, the Global Drug Eluting Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Drug Eluting Stent Market.
Global Drug Eluting Stent market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: